Patents by Inventor Gilberto Santiago

Gilberto Santiago has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240133943
    Abstract: A testing apparatus comprises a test interface board comprising a plurality of socket interface boards, wherein each socket interface board comprises: a) an open socket to hold a DUT; b) a discrete active thermal interposer comprising thermal properties and operable to make thermal contact with the DUT; c) a superstructure operable to contain the discrete active thermal interposer; and d) an actuation mechanism operable to provide a contact force to bring the discrete active thermal interposer in contact with the DUT.
    Type: Application
    Filed: December 11, 2023
    Publication date: April 25, 2024
    Inventors: Karthik RANGANATHAN, Gregory CRUZAN, Samer KABBANI, Gilberto OSEGUERA, Rohan GUPTE, Homayoun REZAI, Kenneth SANTIAGO, Marc GHAZVINI
  • Patent number: 10563269
    Abstract: Processes for detecting Dengue virus (DENV) nucleic acid in a sample are provided including producing an amplification product by amplifying DENV nucleotide sequence and detection of an amplification by hybridization of a probe or other technique. The processes use primers or probes with introduced mutations and or degenerate bases that provide excellent superiority in detection and serotyping of DENV in a sample.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: February 18, 2020
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Jorge L. Munoz-Jordan, Edgardo Vergne, Gilberto Santiago
  • Publication number: 20170275711
    Abstract: Processes for detecting Dengue virus (DENV) nucleic acid in a sample are provided including producing an amplification product by amplifying DENV nucleotide sequence and detection of an amplification by hybridization of a probe or other technique. The processes use primers or probes with introduced mutations and or degenerate bases that provide excellent superiority in detection and serotyping of DENV in a sample.
    Type: Application
    Filed: April 17, 2017
    Publication date: September 28, 2017
    Applicant: The U.S.A., as represented by the Secretary, Department of Health and Human Services
    Inventors: Jorge L. Munoz-Jordan, Edgardo Vergne, Gilberto Santiago
  • Patent number: 9657361
    Abstract: Processes for detecting Dengue virus (DENV) nucleic acid in a sample are provided including producing an amplification product by amplifying DENV nucleotide sequence and detection of an amplification by hybridization of a probe or other technique. The processes use primers or probes with introduced mutations and or degenerate bases that provide excellent superiority in detection and serotyping of DENV in a sample.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: May 23, 2017
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Jorge L. Munoz-Jordan, Edgardo Vergne, Gilberto Santiago
  • Publication number: 20140315745
    Abstract: Processes for detecting Dengue virus (DENV) nucleic acid in a sample are provided including producing an amplification product by amplifying DENV nucleotide sequence and detection of an amplification by hybridization of a probe or other technique. The processes use primers or probes with introduced mutations and or degenerate bases that provide excellent superiority in detection and serotyping of DENV in a sample.
    Type: Application
    Filed: October 25, 2012
    Publication date: October 23, 2014
    Inventors: Jorge L. Munoz-Jordan, Edgardo Vergne, Gilberto Santiago